October 26, 2006

The Crawford Resignation Mystery Sat, 24 Sep 2005 Merrill Goozner of Center for Science in the Public

Read More
The Crawford Resignation Mystery

October 26, 2006

At FDA, Changes In Name Only–Agency Puts Business interests Above Safety Fri, 30 Sep 2005 The sudden

Read More
At FDA, Changes In Name Only–Agency Puts Business interests Above Safety

October 26, 2006

How Did the Vioxx Debacle Happen? USA Today / Lancet Tue, 12 Oct 2004 Dr. Eric Topol

Read More
How Did the Vioxx Debacle Happen? USA Today / Lancet

October 26, 2006

FDA Commissioner Nominee told Senate He’s Open to Independent Safety Unit / Biogen issues Avonex Warning Fri,

Read More
FDA Commissioner Nominee told Senate He’s Open to Independent Safety Unit / Avonex Warning

October 26, 2006

Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the

Read More
Infomail Archive

October 26, 2006

Pfizer CEO earned $16 milion-72% Increase / V-P Tells Congress How to Save $37.8 billion in cost

Read More
Pfizer CEO earned $16 milion – 72% Increase / V-P Tells Congress How to Save $37.8 billion in cost of drugs

October 26, 2006

Corporate Culture of Denial Results in Preventable Deaths Fri, 7 Jan 2005 Failure to disclose the hazardous

Read More
Corporate Culture of Denial Results in Preventable Deaths

October 26, 2006

FDA Commissioner Lester Crawford Resigns – AP Fri, 23 Sep 2005 The Associated Press reports that the

Read More
FDA Commissioner Lester Crawford Resigns – AP

October 26, 2006

Safety of American Drugs Questioned – Assoc Press Thu, 2 Dec 2004 In his CNN news program

Read More
Safety of American Drugs Questioned – Assoc Press

October 26, 2006

FDA Critics Slam Plan for Safety Reform – Nature Thu, 17 Feb 2005 This is smoke and

Read More
FDA Critics Slam Plan for Safety Reform – Nature

October 26, 2006

FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post Thu, 18 Nov 2004

Read More
FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post

October 26, 2006

Cover Letter – AHRP Ethical and Scientific Objections to FDA’s Proposed Licensure of Anthrax Vaccine related links:

Read More
Cover Letter – Comments to FDA Re Anthrax Vaccine

October 26, 2006

Daniel Troy Legacy: Public Virtually Defenseless against Unsafe Drugs Thu, 18 Nov 2004 The Associated Press reports

Read More
Daniel Troy Legacy: Public Virtually Defenseless against Unsafe Drugs

October 26, 2006

Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the

Read More
Infomail Archive, 2005